← Open Payments lookup

XIAOFAN LI: Open Payments

NPI 1962631085 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$262 in 9 payments from 5 companies in 2025. Trend: 2023 $466 · 2024 $307 · 2025 $262

Food & beverage: $262
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$141
Teva Pharmaceuticals USA, Inc.3$56
Lundbeck LLC2$35
E.R. Squibb & Sons, L.L.C.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: INGREZZA, AUSTEDO XR, REXULTI, COBENFY, UZEDY, CAPLYTA.

Industry payments across TX — which companies pay providers there.